All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Oxyphilic Adenocarcinoma | NCIT_C3679 | [An adenocarcinoma characterized by the presence of large malignant epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes). Representative examples include thyroid gland oncocytic follicular carcinoma, oncocytic breast carcinoma, and salivary gland oncocytic carcinoma.] |
| Interleukin 33 Measurement | NCIT_C74831 | [The determination of the amount of interleukin 33 present in a sample.] |
| Interleukin 4 Measurement | NCIT_C74832 | [The determination of the amount of interleukin 4 present in a sample.] |
| Interleukin 5 Measurement | NCIT_C74833 | [The determination of the amount of interleukin 5 present in a sample.] |
| Celgene | NCIT_C126405 | [An American biotechnology company that manufactures drug therapies for cancer and inflammatory disorders.] |
| Company | NCIT_C54131 | [Any formal business entity for profit, which may be a corporation, a partnership, association or individual proprietorship.] |
| Kite Pharma | NCIT_C126406 | [A clinical-stage biopharmaceutical company engaged in the development of cancer immunotherapy products with a primary focus on engineered autologous T cell therapy designed to restore the immune system's ability to recognize and eliminate tumors.] |
| Bluebird Bio | NCIT_C126407 | [A clinical-stage biotechnology company using gene therapy, cancer immunotherapy, and gene editing to treat and cure genetic diseases and cancer.] |
| Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma | NCIT_C126408 | [A rare morphologic variant of papillary thyroid gland carcinoma characterized by the presence of solid, cribriform, and squamoid-morular areas.] |
| Acetylcholine Measurement | NCIT_C74838 | [The determination of the amount of acetylcholine hormone present in a sample.] |
| Bronchial Epithelial Dysplasia | NCIT_C126401 | [A non-invasive, precancerous lesion in the bronchial epithelium. Depending on the morphologic features it is classified as columnar cell dysplasia, basal cell dysplasia, squamous dysplasia, or bronchial epithelial dysplasia with transitional differentiation.] |
| Adiponectin Measurement | NCIT_C74839 | [The determination of the amount of adiponectin hormone present in a sample.] |
| Near-Infrared Fluorescence Imaging | NCIT_C126402 | [Fluorescence imaging using dyes that fluoresce in the near-infrared range. NIR optical imaging permits relatively deep photon penetration into tissue, minimal tissue auto-fluorescence, less scatter, and high optical contrast.] |
| Fluorescence Imaging | NCIT_C116489 | [An imaging technique that uses fluorescent dye to achieve the desired image.] |
| Novartis | NCIT_C126403 | [A Swiss multinational pharmaceutical company that is engaged in the development, manufacturing, and marketing of healthcare products.] |
| Juno Therapeutics | NCIT_C126404 | [A clinical-stage company developing cellular immunotherapies based on Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies.] |
| Interleukin 6 Measurement | NCIT_C74834 | [The determination of the amount of interleukin 6 present in a sample.] |
| Interleukin 7 Measurement | NCIT_C74835 | [The determination of the amount of interleukin 7 present in a sample.] |
| Interleukin 8 Measurement | NCIT_C74836 | [The determination of the amount of interleukin 8 present in a sample.] |
| Interleukin 9 Measurement | NCIT_C74837 | [The determination of the amount of interleukin 9 present in a sample.] |